PRESENTATION
FY2023 — Results presentation
FY2023PDF · 74 pages5.1 MB
AUDITED RESULTS For the year ending 30 June 2023 -- 1 of 74 -- 2 Normalised operating profit +24% to R11 661m Normalised headline earnings +32% to R7 678m Headline earnings +5% to R5 490m Core new business +12% to R22 788m Excluding discontinued products like VitalityInvest and Ping An Health reinsurance business Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health Vitality Health Vitality Life USA -- 2 of 74 -- 3 1 2 3 Growing quality earnings with a robust balance sheet A clear strategy per composite, intensifying focus on key initiatives and ceasing those with marginal benefits 4 +12% New business 64%Cash conversion +24%Operating profit 20% FLR 10.6% Investment in New excl discontinued UK Transitioning to IFRS 17 Evolving the Vitality Shared-Value Insurance Model -- 3 of 74 -- 4 0% 20% 40% 60% 80% 100% 120% 140% New business Lapses Claims SA composite UK composite Group average Projections 0% 1% 2% 3% 4% 5% 6% 7% 8% 9% 2021 2022 2023 2024 World South Africa United Kingdom United States China 1 Source: International Monetary Fund, World Economic Outlook, July 2023 Update 2 Sources: US Bureau of Labour statistics, StatsSA, Statista, Office for National Statistics 3 Source: Bank for International Settlements Central bankers remaining cautious despite inflation cooling globally Actuarial dynamics remain robust Global growth under pressure Real GDP growth1 0% 1% 2% 3% 4% 5% 6% 7% 8% 9% Jan-21 May-21 Sep-21 Jan-22 May-22 Sep-22 Jan-23 May-23 South Africa United Kingdom United States China -2% 0% 2% 4% 6% 8% 10% 12% Jan-21 May-21 Sep-21 Jan-22 May-22 Sep-22 Jan-23 May-23 United States South Africa China United Kingdom CPI inflation rates2 Central bank policy rates3 Volatile exchange rates 80 85 90 95 100 105 110 115 120 125 130 Jan-2022 Mar-2022 May-2022 Jul-2022 Sep-2022 Nov-2022 Jan-2023 Mar-2023 May-2023 USDZAR GBPZAR USD/ZAR and GBP/ZAR exchange rates New business (YoY), claims and lapses AvE -- 4 of 74 -- 5 Health 3 854 +7% 8 678 +19% 1 201 +10% Life 4 807 +19% 2 838 +12% Invest 1 560 +30% 3 050 +4% Insure 62 +138% 1 249 +0% Bank -767 -23% 1 517 +60% Other SA initiatives -312 +28% 631 -25% Central costs -124 n/a SA 9 096 +22% 16 818 +11% 2 718 +33% VitalityHealth 1 283 -3% 2 064 +19% VitalityLife 1 039 +55% 1 721 +37% Closure costs of Vitality Invest and Vitality Car -455 -0% Other initiatives and central costs -79 +32% UK 1 788 +21% 3 785 +26% Vitality Network 411 +26% 2 2223 +59% VHI - Other -195 +1% VHI - Ping An Health Insurance 596 +76% 2 1852 -1% Other initiatives and central costs -35 +46% Vitality Global 777 +74% 2 185 -1% 2 2223 +59% Operating profit New business1 2 PAHI own licence +24% R11 661m +12% R22 788m 1 Excl products in run down Non-insurance income +44% R4 940m ZARm 3 VG income excludes cost recoveries and rewards -- 5 of 74 -- 6 Operating profit Core new business API Total income from non-insurance business lines - 1,000 2,000 3,000 4,000 5,000 FY19 FY20 FY21 FY22 FY23 R4 940m R11 661m R22 788m - 2,000 4,000 6,000 8,000 10,000 12,000 - 2,500 5,000 7,500 10,000 12,500 15,000 17,500 20,000 22,500 New COVID-19 COVID-19 -- 6 of 74 -- 7 Decreased investment in New Initiatives Going forward • Discovery Bank due to reach operational break-even in FY24 • Africa Health merged into Discovery Health to provide focused health expertise to multinational clients in Africa • Umbrella Funds to be absorbed into a focused Corporate and Employee Benefits business unit • Vitality1 to be folded into Vitality Global • Vitality Invest to be closed by end of CY23 • Vitality Health International a key expansion strategy for Vitality Global 0% 5% 10% 15% 20% 25% 2017 2018 2019 2020 2021 2022 2023 Investment in New Initiatives (%) 1 VitalityInvest and VitalityCar write-down Discontinued UK businesses1 10.6% 13.6% incl. discontinued UK initiatives 10% target -- 7 of 74 -- 8 Opening EV Value of new business Unwind of risk discount rate Non-economic experience variances and methodology & assumption changes Operational EV Economic experience variances and methodology & assumption changes Forex New Initiatives Other Closing EV R98 176m R98 711m R86 258m Operational EV Economic and other Economically driven Positive non- economic experience variances (Rm) Health1 703 Life 521 VitalityHealth 555 VitalityLife 819 Total 2 598 Positive variances 13.2% RoEV 1 Health and Vitality -- 8 of 74 -- 9 1 Considers cash at centre, Discovery Life, Discovery Insure, VitalityHealth, VitalityLife and Discovery Bank 2 Capital Adequacy Ratio 3 Comprehensive Solvency Ratio, definition set by China Banking and Insurance Regulatory Commission 4 Centre cash + undrawn committed facilities Highly liquid across the Group FLR within target Sufficient liquidity Strongly capitalised DHMS solvency (unaudited) 30.2% Jun 22 Cover Jun 23 Cover Life 1.7x 1.9x Insure 1.2x 1.6x VH 1.5x 1.4x VL 2.1x 2.1x Bank2 1.3x 1.3x PAHI3 2.8x 2.7x 14% 16% 18% 20% 22% 24% 26% 28% 30% FY17 FY18 FY19 FY20 FY21 FY22 FY23 FLR 20.4% 28% Centre liquidity4 , R millions - 500 1,000 1,500 2,000 2,500 3,000 FY18 FY19 FY20 FY21 FY22 FY23 - 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 FY19 FY20 FY21 FY22 FY23 Liquid assets across the Group1, R millions 64% Cash conversion -- 9 of 74 -- 10 Rm 12 months ended Jun 2022 12 months ended Jun 2023 % Normalised profit from operations before economic assumptions adjustments 9 384 11 661 +24% Economic assumptions adjustment DL -651 -2 811 Economic assumptions adjustment VL 567 147 Time value of swaption -454 -204 Investment income and fair value gains on financial instruments 219 538 Finance charges excl. 1DP finance lease -1 385 -1 664 Vaccination costs -157 - Other (including IFRS reporting adjustments) -254 -277 Profit before tax 7 269 7 390 +2% Tax -1 790 -2 070 Profit not attributable to ordinary shareholders -57 -152 Loss on impairment and derecognition 44 302 Other headline earnings adjustments -262 20 Headline earnings 5 204 5 490 +5% Economic assumptions adjustment (DL and VL) after tax and hedging 10 1 936 Other 602 252 Normalised headline earnings 5 816 7 678 +32% 1 2 1 The sharp rise in both nominal and real interest rates in SA resulted in Discovery Life economic assumptions adjustments of R2 811 million 2 Lower effective tax rate in prior year with a significant driver being the DTA adjustment arising from a decrease in SA corporate tax rate to 27% -- 10 of 74 -- 11 0.0% 0.5% 1.0% 1.5% 2.0% 2.5% 3.0% 3.5% 4.0% 4.5% 5.0% Jan 2016 Jan 2017 Jan 2018 Jan 2019 Jan 2020 Jan 2021 Jan 2022 Jan 2023 First hedge and swaption purchased Hedges moved onto PAC book Hedge strategy simplified 0% 1% 2% 3% 4% 5% 6% 1 16 31 46 61 76 91 106 121 136 151 166 181 196 211 226 241 256 271 286 By duration Jun 19 Jun 22 Jun 23 Nominal rate curve Real rate curve 4% 6% 8% 10% 12% 14% 16% 1 16 31 46 61 76 91 106 121 136 151 166 181 196 211 226 241 256 271 286 By duration Jun 19 Jun 22 Jun 23 Significant movements in SA yield curves impacted Discovery Life earnings UK hedging strategy led to lower IFRS 4 earnings volatility in VitalityLife Under IFRS 17, OCI will reduce the volatility of IFRS earnings and effectively amortise changes over time -4,000 -3,500 -3,000 -2,500 -2,000 -1,500 -1,000 -500 0 500 FY20 FY21 FY22 FY23 -4,000 -3,500 -3,000 -2,500 -2,000 -1,500 -1,000 -500 0 500 FY20 FY21 FY22 FY23 Economic assumptions adjustments (Rm)1 Economic assumptions adjustments (Rm)1 UK 25-year SONIA rate 1 Economic assumptions adjustments before tax, net of VL hedging impacts -- 11 of 74 -- 12 Dividend declaration of 110cps in respect of H2 FY23. In future, interim ordinary dividends are expected to be paid in the range of 30%-40% of the expected total annual ordinary dividend, in line with market practice, with the remainder of the dividend to be paid as a final dividend Rm 12 months ended Jun 2022 12 months ended Jun 2023 % Normalised profit from operations before economic assumptions adjustments 9 384 11 661 +24% Economic assumptions adjustment DL -651 -2 811 Economic assumptions adjustment VL 567 147 Time value of swaption -454 -204 Investment income and fair value gains on financial instruments 219 538 Finance charges excl. 1DP finance lease -1 385 -1 664 Vaccination costs -157 - Other (including IFRS reporting adjustments) -254 -277 Profit before tax 7 269 7 390 +2% Tax -1 790 -2 070 Profit not attributable to ordinary shareholders -57 -152 Loss on impairment and derecognition 44 302 Other headline earnings adjustments -262 20 Headline earnings 5 204 5 490 +5% Economic assumptions adjustment (DL and VL) after tax and hedging 10 1 936 Other 602 252 Normalised headline earnings 5 816 7 678 +32% 1 2 1 The sharp rise in both nominal and real interest rates in SA resulted in Discovery Life economic assumptions adjustments of R2 811 million 2 Lower effective tax rate in prior year with a significant driver being the DTA adjustment arising from a decrease in SA corporate tax rate to 27% -- 12 of 74 -- 13 Volatility of future earnings buffered by CSM and the use of OCI Discovery’s earnings are approaching cross-over IFRS 17 margins increase by cR15bn with a concomitant cR12.5bn reduction in shareholder equity Value is largely unchanged 1 2 3 4 -- 13 of 74 -- 14 Main businesses Impact resulting from IFRS 17 Health Not applicable Life (Individual) Significant Life (Group) Minimal Invest Significant Insure Minimal Bank Not applicable VitalityHealth Minimal (but some impact regarding acquisition costs) VitalityLife Significant VHI - Ping An Health Insurance Minimal (but some impact regarding acquisition costs) Vitality Network Not applicable Vitality Health International Not applicable No change in underlying value nor underlying economics • No direct change to cash flows, underlying risk and reward of contracts. Tax cash flow impact expected to be immaterial • No impact on regulatory or economic solvency, capital position or capital management • Immaterial impact on Embedded Value • Ability to pay dividend unaffected as cash flows and solvency remain unchanged Accounting standard change that effects the timing of profit recognition, therefore affects transitional balance sheet 1 2 -- 14 of 74 -- 15 Total value the same but reallocated 1 2 2 Three conceptual value drivers Total value the same meaning that value shifts between equity and margins BEL is similar in nature and size to NEFCF Best estimate of future cash flows (BEL) Compulsory margin IFRS 4 Discretionary margin Equity of ordinary shareholders IFRS 17 Net expected future cash flows (NEFCF) Risk adjustment (RA) Contractual service margin (CSM) Equity of ordinary shareholders (incl OCI) Future cash flows Margins Shareholder equity PV future cashflows PV future profits PV past profits Assets Margins and equity 1 -- 15 of 74 -- 16 1 Average over the past 5 years Concentrated in long-term whole of life business with large upfront acquisition costs Change in expense recognition and recognising onerous contracts IFRS 17 is much more specific on what is non-directly attributable and so are not offset by margins; hence margins are preserved under IFRS 17 and released as profits later IFRS 4 IFRS 17 Under Discovery’s application of IFRS 4 all acquisition expenses were included when ensuring a zero profit on initial recognition Policy administration and maintenance costs Commission payments Underwriting costs Claim assessment and other claim-related costs Directly attributable allocated fixed and variable overheads Vitality Life Discovery Life Launch 2016 2000 Relatively young life insurance companies ACI increases 4-9% 11.5%1 Rapidly growing Proportion of life insurance business 100% 80% Mono-line Average contract boundary 35 years 50 years Long-term contracts Commission as % of first year premium 210% 85% High upfront acquisition costs 5% 95% Marketing and sponsorships Group executive and Group functions Research and development activities of new products Corporate initiatives Directly attributable under IFRS 17 Non-directly attributable under IFRS 17 Discovery expenses 1 2 Under IFRS 17 onerous contracts immediately expensed, thereby preserving margins on profitable contracts -- 16 of 74 -- 17 Simplified illustration IFRS 4 IFRS 17 Duration Annual p rofit 𝑨 𝑩 Pre-cross-over Post-cross-over Discovery’s life businesses on transition from IFRS 4 to IFRS 17: Annual earnings depend on where in time the cross-over is Margins always increase Shareholder equity always decreases Earnings Duration Margin balance Duration Equity IFRS 4 IFRS 17 IFRS 4 IFRS 17 Margin Shareholder equity The cross-over point is the most optimal because earnings would be the same, margins would increase and the impact on equity is at a maximum 1 2 3 4 1 2 3 4 Layering on new business Run-off of an individual cohort -- 17 of 74 -- 18 Drivers of the margin and equity change Total value largely unchanged Strengthening of margins mirrored by a reduction of equity in range of R12bn to R13bn (R12.5bn used in the illustration) Total margins strengthened by cR15bn as at 1 July 2022 Non-directly attributable expenses under IFRS 17 Cohorting and onerous contracts: immediate expensing of loss making (onerous) contracts under IFRS 17 Other: impacts incl. different treatment of basis changes and discount rates through the margin under IFRS 17 Non-attributable expenses: R6.5bn R9.0bn pre-tax Onerous: R3.5bn R4.5bn pre- tax Other: R1.0bn R1.5bn pre-tax IFRS equity R53.5bn Deferred tax IFRS 4 margins IFRS 4 IFRS 17 FY 22 EFCF diff IFRS equity R41bn RA R10bn CSM R34bn IFRS 4 IFRS 17 Duration Annual p rofit Discovery Life Vitality Life 1 Proportion of FY22 non-directly attributable expenses to the total Discovery marketing and administration and acquisition costs for insurance business lines 2 Proportion of FY22 portfolio that is onerous 1 2 3 Group is approaching cross-over c5% of total expenses1 onerous2 c9% Discovery Group’s cross-over will lag Discovery Life’s, and its earnings as a whole under IFRS 17 are not expected to be significantly different to the IFRS 4 normalised operating profit in the interim, as the other businesses are largely unaffected -- 18 of 74 -- 19 Future earnings should be less volatile due to additional CSM - buffering against basis changes for non-economic variances and a more stable release of profits. The use of OCI also buffers against basis changes for economic variances and reclassifies to profit or loss on systematic variances Overall, on transition to IFRS 17, Discovery is approaching the cross-over point, at which point earnings will be at the same level as under IFRS 4, and from there should continue to grow more strongly with the release of the additional margin over time IFRS 17 margins will increase by cR15bn (gross of tax) and shareholder equity will reduce by a concomitant cR12.5bn (net of tax) The value stays largely the same On transition to IFRS 17: -- 19 of 74 -- 20 Making people healthier1 Restoring the climate and environment Strengthening healthcare system and nation building Ensuring diverse and inclusive workforce, leadership and board7 Ensuring fair and responsible pay 2 3 4 5 Focus areas and FY23 outcomes 503m (+15%) >3m (>2m) R13.7bn (+20%) Healthy activities recorded1 Life years saved2 Shared-value dividend3 18.5% Lower carbon emissions5 Female Black Staff +3% (65%) +5% (88%) Leadership +0% (52%) +2% (63%) Group Exec Committee +2% (19%) +5% (26%) ESG Ratings Peer rating4 Highest 19.4 #1 81% 2023 2023 2023 1 Healthy activities include relevant physical activity events recorded and HealthyFood purchases; the prior year was restated to 438m to allow for duplications ; 2 Life years saved is calculated from healthy activities recorded, using the methodology in the informed by the Habit Index; 3 Includes R6.25bn and R6.33bn Shared-value and rewards returned to customers respectively and R1.15bn DHMS dividend from Vitality; 4 Relative to domestic life insurance peer group; 5 Relative to 2019 base, measured by Scope 1 + Scope 2 emissions, before verification ; 6 Potholes filled to date, with growth rate measured at June 2023; 7 ‘Leadership’ and ‘staff’ is for SA, with Black including AC and I; 8 Relative to SA financial services group; 4,6 Discovery Green Renewable energy platform launched 1 2023 B-BEE level Minimum pay R180,000 threshold more than 3x prescribed min pay in SA Gender pay Gap Has been closed to ~0% for same-role size 41m (+2%) Lives impacted R33m Fund contribution Essential healthcare services in rural communities R12m research grants Predominantly black medical public sector specialists Board targets achieved 38% Black directors 38% Female directors ~190,000 (+57%) Potholes filled through Pothole Patrol6 2nd of 19 Lowest income disparity ratio8 Lowest Carbon emitter4,5 -- 20 of 74 -- 21 -- 21 of 74 -- 22 Provides opportunity to impact the following key variables: UNDERWRITING PREMIUMS CLAIMS AND EXITS 1 2 3 Acquisition and Underwriting Dynamic Pricing Dynamic Risk Assessment Personalised Engagement Sales and Retention Data Life Health The rate of mortality The cost of morbidity The rate of lapse The rate of upsell Product competitiveness and the rate of sales 𝑞𝑥 𝑠𝑥 𝑙𝑥 Valuation Models -- 22 of 74 -- 23 Behavioural data Acquisition, underwriting and pricing Traditional life insurance models Claims Acquisition, underwriting Shared-value life insurance models Dynamic Pricing Dynamic risk assessment Engagement and behaviour change Claims 1 Lifestyle data Exercise. Sleep. Nutrition. Biometrics. Alcohol Engagement Propensity Resilience 2 Digital Data Ingestion and Selective Probing Personalised Risk Algorithm Actuarial, resonance and habit optimisation Hyper- personalized pathways Next Best Action and incentives Valuation module Sales & selection effect Behavioural effect Lapse effect Dynamic pricing model Wedge pricing model Fund boost model Differential assumptions and transitions Archetypes GLOBAL -- 23 of 74 -- 24 Acquisition, underwriting Shared-value model in health Dynamic Risk Assessment Engagement and behaviour change Claims and retention Value based care Joint venture developing a data science platform with AI- driven personalised health recommendations Africa Health Insurance USA Health -- 24 of 74 -- 25 *Interim results and pathways, subject to change Up to 40 actions for this member Newly diagnosed Type 2 diabetic, female, age 50, no other co-morbidities savings per annum if all diabetics exercise >3 times per week Increase in physical activity reduces healthcare costs by R4 200 p.a. Regular pathology testing (HBa1C and Lipogram) reduces costs by R4 000 p.a. Adherence to chronic medication reduces healthcare costs by R2 000 p.a. Take your medication 3 Moves Visit your doctor 6 Moves Walk 10 00 steps 6 Moves Walk 10 000 steps -- 25 of 74 -- 26 GLOBAL -- 26 of 74 -- 27 • Scaling the Bank to profit and positioning it as the face of the composite • Ensuring each business is market leader in terms of market share, margin, product and customer value • Scaling Ping An Health Insurance in a complex Chinese market • Monetising and scaling IP in Vitality Network with key partners • Globalising unique health assets • Growing VitaltyHealth on the back of a complex NHS environment • Using the Shared-Value Model to get superior ROC and growth in VitalityLife • Integration of Life and Health Perfect composite model, #1 in our chosen segments in every industry, and the Bank pivoting to growth as the composite-maker within SA A new generation life and health insurance composite, with integration at both a product and operational level and a seamless One Vitality client journey Leading wellness and healthcare platform that provides preeminent life and health insurers globally with our Vitality shared-value and health management capabilities to assist them in making their customers healthier, while ensuring their products are more competitive with better margins -- 27 of 74 -- 28 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 28 of 74 -- 29 Jul-19 Dec-19 May-20 Oct-20 Mar-21 Aug-21 Jan-22 Jun-22 Nov-22 Apr-23 +22% Total clients Advances Net income Retail deposits Operating result Total accounts -R767m Rm +67% Jul-19 Dec-19 May-20 Oct-20 Mar-21 Aug-21 Jan-22 Jun-22 Nov-22 Apr-23 Jul-19 Dec-19 May-20 Oct-20 Mar-21 Aug-21 Jan-22 Jun-22 Nov-22 Apr-23 +36% +49% +59% to R14.3bn to >700k to 1.6m to R1.2bn to R5.2bn -1,400 -1,200 -1,000 -800 -600 -400 -200 0 2019 2020 2021 2022 2023 New business acquisition costs (NBAC) Loss before NBAC 2019 2020 2021 2022 2023 -- 29 of 74 -- 30 0 20 40 60 80 100 120 140 2021-Jan 2021-Apr 2021-Jul 2021-Oct 2022-Jan 2022-Apr 2022-Jul 2022-Oct 2023-Jan 2023-Apr NII NIR Accelerating growth in client base Increasing engagement over time High NIR compared to the market Rapid growth in revenue Average sales per work day NII and NIR per month NIR per customer NIR by duration 0 200 400 600 800 1,000 1,200 Jan-20 May-20 Sep-20 Jan-21 May-21 Sep-21 Jan-22 May-22 Sep-22 Jan-23 May-23 177 0 20 40 60 80 100 120 140 160 180 200 1 2 3 4 5 6 7 8 9 10 11 12 Duration in force 55% CAGR 1,963 1,842 1,528 1,398 1,262 536 Bank A Discovery Bank Bank B Bank C Bank D Bank E -- 30 of 74 -- 31 0% 1% 2% 3% 4% 5% 6% 7% 8% 9% Jan-22 Feb-22 Mar-22 Apr-22 May-22 Jun-22 Jul-22 Aug-22 Sep-22 Oct-22 Nov-22 Dec-22 Jan-23 Feb-23 Mar-23 Apr-23 May-23 Jun-23 Bank A Bank B Bank C Bank D Superior credit quality Stable credit losses despite rate hikes Expanding credit offerings R250bn in home loan balances Volume distribution of existing accounts1 Credit loss ratio2 Q4 2023 Staff and adviser pilot Market launch Market launch Q1 2024 Q2 2024 1 Source: BA900, Transunion report 2 Including overlays and IFRS adjustments Big 4 Discovery Bank clients’ advances as at Aug 23 (Rbn) Discovery Bank Market 250 346 25 48 18 23 Outstanding balance Limits Home loans Credit card Personal loans Subprime Near prime Prime Prime plus Super prime Subprime Near prime Prime Prime plus Super prime -- 31 of 74 -- 32 Expense efficiencies realised as the Bank continues to scale Operating leverage as more products are added Reaching breakeven earlier than expected - 20 40 60 80 100 120 Jan-22 Mar-22 May-22 Jul-22 Sep-22 Nov-22 Jan-23 Mar-23 May-23 Jul-23 Average net income pc Expenses pc Expenses and income per customer Profit before new business acquisition costs Fixed and variable costs over time Discovery account Life Bank integrator Share trading Travel in Bank app AR3.0 Payshap Jul-23 Sep-23 Nov-23 Jan-24 Mar-24 May-24 Jul-24 Sep-24 Nov-24 Jan-25 Mar-25 May-25 Jul-25 Sep-25 Nov-25 February 23 expectations Current expectations Access facilities Home loans Jul-20 Sep-20 Nov-20 Jan-21 Mar-21 May-21 Jul-21 Sep-21 Nov-21 Jan-22 Mar-22 May-22 Jul-22 Sep-22 Nov-22 Jan-23 Mar-23 May-23 Fixed costs Variable costs -- 32 of 74 -- 33 Discovery portfolio is linked directly to Vitality Health, Vitality Drive and Vitality Money behavioural platforms Rewards monetised in Discovery Miles Shared Value currency Integrated ecosystems enabled by Discovery Bank operating system and third-party partnerships Banking portfolio Discovery Portfolio New lending products Health claim s We have received your latest claim from your recent consultation w ith Dr Da Svel for R956.27. Your claim will be settled as follows: Total paid by MSA: R 756.17 Total paid by HealthPay: R 200.10 Balance owed to provider: R 0.00 Your available balances are: MSA: R 15,200.32 Discov ery Bank Black Card: R 25,327.66 Tap here to see full details Healt h Pay Clai m s no t if icat i on Banking portfolio underpinned by digital payments capabilities -- 33 of 74 -- 34 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 34 of 74 -- 35 Jan-18 Jun-18 Nov-18 Apr-19 Sep-19 Feb-20 Jul-20 Dec-20 May-21 Oct-21 Mar-22 Aug-22 Jan-23 Jun-23 Healthy Company Gap Cover Flexicare 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019 2021 2023 Non Scheme Products Restricted Schemes DHMS 2019 2020 2021 2022 2023 2019 2020 2021 2022 2023 Operating profit New business Non-scheme growth Membership +7% +19% >3.8m to R3 854m to R8 678m Lives under administration Lives >321k Revenue R1.5bn -- 35 of 74 -- 36 DHMS Rest of Industry Gross lives Withdrawing lives Solvency and reserves as at June 2023 Membership Customer satisfaction Solvency Lapses 57.8% market share Others 0% 1% 2% 3% 4% Jan-19 Jan-20 Jan-21 Jan-22 Jan-23 Upgrade Downgrade Less members are changing their plans: R26.9bn 30.2% AAA 0% 5% 10% 15% 20% 25% 30% 35% 40% - 5 10 15 20 25 30 35 2019 2020 2021 2022 2023 Reserve Actual Solvency Required Solvency unaudited reserves unaudited solvency credit rating R billion ~303k lives Gross activations vs withdrawing lives over the last 24 months, with lapses remaining stable: ~284k lives Left employer Affordability Provider change Death Emigration Other 97% No plan changes Awards recognising exceptional service: Health Product Provider of The Year #1 ranked health insurer amongst employers, providers and brokers based on independent survey results -- 36 of 74 -- 37 A change to Section 33 is required to enable private sector collaboration “33. Once National Health Insurance has been fully implemented as determined by the Minister through regulations in the Gazette, medical schemes may only offer complementary cover to services not reimbursable by the Fund” Status quo is unsustainable, universal healthcare is crucial and NHI a remedy Discovery’s position: NHI is not workable without private sector collaboration -- 37 of 74 -- 38 The private sector has significant scale And is delivering exceptional value for members Outstanding comprehensive cover, with excellent outcomes Meeting the highest international standards While remaining cost effective in a challenging environment Achieved in a highly regulated sector: Guaranteed access to cover Comprehensive prescribed minimum benefits Higher income countries South Africa Cost of cover (PPP adjusted) – 38% 86% 85% 56% 14% Prostate Breast Colon Lung High cancer survival rates observed in the medical aid population, in line best health systems >96% cancer coverage for medical scheme patients, as per CMS research, including cover for innovative, high-cost drugs US Standard Discovery Health Readmission rates for over 65s – 7% 83% HbA1C testing rate for diabetes patients – in line with US benchmarks Open Medical Schemes 4.8m lives Closed Medical Schemes 4m lives 838 private facilities 42k hospital beds 7.3k GPs 47k nurses 7k specialists 3.5k dentists 2.5k optometrists 3.6k psychologists Community rated, open to selection Non-mandatory membership -- 38 of 74 -- 39 However, funding the additional required spend through tax increases on a small base is not sustainable R200bn Additional funding required per annum, as indicated by the National Department of Health 31% increase in personal income tax or; 6.5% increase in VAT (from 15% to 21.5%) or; 10x increase in payroll tax (current UIF contributions). -- 39 of 74 -- 40 0 500 1000 1500 2000 2500 Current funding for uncovered lives With additional R200bn For the population using the public sector For the medical scheme population Healthcare funding available per person remains insubstantial: R425ppm R684ppm 0 500 1000 1500 2000 2500 Current private medical schemes Current NHI proposal Significant reduction in healthcare funding: R684ppm R2 346ppm – 71% While the rise in spend for South Africans using the public sector is significant, the overall population’s healthcare remains insubstantial at R684ppm The medical scheme population will pay 31% more tax and get 71% less healthcare, including a significant portion of pensioners with the highest healthcare needs -- 40 of 74 -- 41 Countries with a private healthcare insurance market Countries without a private healthcare insurance market Afghanistan Azerbaijan Brunei Darussalam Cook Islands Cuba Eritrea Iceland Iraq Kiribati Lesotho Malta Nauru Niue Norway Papua New Guinea Solomon Islands Timor-Leste 17 countries 169 countries In all countries listed, the absence of private health insurance is attributable to market dynamics, not a legislative ban Algeria Central African Republic Gambia Lebanon Oman South Sudan Andorra Chad Georgia Liberia Pakistan Spain Angola Chile Germany Lithuania Palau Sri Lanka Antigua and Barbuda China Ghana Luxembourg Panama Sudan Argentina Colombia Greece Madagascar Paraguay Suriname Armenia Comoros Grenada Malawi Peru Sweden Australia Congo Guatemala Malaysia Philippines Switzerland Austria Costa Rica Guinea Maldives Poland Tajikistan Bahamas Côte d'Ivoire Guinea-Bissau Mali Portugal Thailand Bahrain Croatia Guyana Marshall Islands Qatar Togo Bangladesh Cyprus Haiti Mauritania Republic of Korea Tonga Barbados Czechia Honduras Mauritius Republic of Moldova Trinidad & Tobago Belarus DRC Hungary Mexico Romania Tunisia Belgium Denmark India Micronesia Russian Federation Türkiye Belize Djibouti Indonesia Monaco Rwanda Turkmenistan Benin Dominica Iran Mongolia Saint Kitts and Nevis Tuvalu Bhutan Dominican Republic Ireland Montenegro Saint Lucia Uganda Bolivia Ecuador Israel Morocco Saint Vincent and the Grenadines Ukraine Bosnia & Herzegovina Egypt Italy Mozambique Samoa United Arab Emirates Botswana El Salvador Jamaica Myanmar San Marino United Kingdom Brazil Equatorial Guinea Japan Namibia Sao Tome and Principe United Republic of Tanzania Bulgaria Estonia Jordan Nepal Senegal United States of America Burkina Faso Eswatini Kazakhstan Netherlands Serbia Uruguay Burundi Ethiopia Kenya New Zealand Seychelles Uzbekistan Cabo Verde Fiji Kuwait Nicaragua Sierra Leone Vanuatu Cambodia Finland Kyrgyzstan Niger Singapore Venezuela Cameroon France Lao Nigeria Slovakia Vietnam Canada Gabon Latvia North Macedonia Slovenia Zambia Zimbabwe -- 41 of 74 -- 42 A change to Section 33 is required to enable private sector collaboration “33. Once National Health Insurance has been fully implemented as determined by the Minister through regulations in the Gazette, medical schemes may only offer complementary cover to services not reimbursable by the Fund” Status quo is unsustainable, universal healthcare is crucial and NHI a remedy Discovery’s position: NHI is not workable without private sector collaboration -- 42 of 74 -- 43 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 43 of 74 -- 44 2023 Normalised operating profit New business Maintained leading market share position Strong capital and liquidity +19% +12% to R4 807m to R2 838m NMG Market Share survey Q2 2023 Quarter ending June 2023 27.1% 30.2% 12 months to June 2023 Group life returned to profitability Individual life: +8% 2019 2020 2021 2022 2023 2019 2020 2021 2022 2023 SCR coverage Liquidity coverage 2023 188% R3 112m 1 X ILT 125% SCR Target Life and Invest Strong cashflow generation Life and Invest cash flow > 30% of net of tax normalised earnings Premium and Fees Claims Operational costs Cashflows from existing New business strain Net Finre Net Cashflow R2 125m R4 934m R19 523m -- 44 of 74 -- 45 Persistency Mortality and morbidity Premium and fee income Policy alterations Other Total Non-Economic Economic Total Life and Invest Positive operating variances Strong EV growth +8.1% RoEV R275m Discovery Life Ltd variances (Rm) Jun-22 New Business Expected unwind incl New Business Experience Variances Methodology and Assumption Changes Total before Economic Impact Experience Variances Methodology and Assumption Changes Components below the line Jun-23 R38 433m R41 145m R42 609m Non- economic +11% Economic +7% R1 064m 0% 20% 40% 60% 80% 100% 120% H1 H2 Improvements in mortality & morbidity experience vs H1 0% 1% 2% 3% 4% 5% 6% 7% VNB margin before economic and expense impact Economic Unit expenses June 23 net VNB 5.7% IRR above RFR 2.54% 6.34% VNB margin (%) • Unit expense pressure, driven by affluent protection market lagging pre-COVID levels • Initiatives to improve margins include expense efficiency drive, driving growth through product innovation and adjacencies and growing the distribution footprint VNB margin impacted by yield movements -- 45 of 74 -- 46 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 46 of 74 -- 47 1 Shared-Value dynamics for the Single Premium Retirement annuity, five-year average Normalised operating profit New business Assets under administration +30% +4% +15% to R1 560m to R3 050m to R140bn (R153bn including Umbrella Funds) 2019 2020 2021 2022 2023 Profit excl. once-offs Once-offs +14% excl. once-offs - 20 40 60 80 100 120 140 160 Jul 2017 Dec 2017 May 2018 Oct 2018 Mar 2019 Aug 2019 Jan 2020 Jun 2020 Nov 2020 Apr 2021 Sep 2021 Feb 2022 Jul 2022 Dec 2022 May 2023 Linked Non-linked UF 2019 2020 2021 2022 2023 H1 H2 Positive dynamics from Shared-value model Withdrawal rates by boost (relative to no boost)1 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% No boost Medium boost High boost 62% lower -- 47 of 74 -- 48 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 48 of 74 -- 49 Gross written premium Gross new business Normalised operating profit Vehicles insured +10% +0% +138% -2% to R5.3bn to R1 249m to R62m to 289 963 2018 2019 2020 2021 2022 2023 2018 2019 2020 2021 2022 2023 2018 2019 2020 2021 2022 2023 2018 2019 2020 2021 2022 2023 -- 49 of 74 -- 50 50 60 70 80 90 100 110 120 130 H1 FY19 H2 FY19 H1 FY20 H2 FY20 H1 FY21 H2 FY21 H1 FY22 H2 FY22 H1 FY23 H2 FY23 90 95 100 105 110 115 120 Q4 FY20 Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q3 FY22 Q4 FY22 Q1 FY23 Q2 FY23 Q3 FY23 Q4 FY23 Average accident cost per claim Average motor premium MTIs = mid-term increases Recovered from COVID under-pricing Improvement in loss ratio Model leading to positive dynamics Margin continues to recover Total loss ratio (rebased) Operating profit margin Average cost vs premium (rebased) 100 89 73 66 57 Blue Bronze Silver Gold Diamond Loss ratio by status (relative to blue) MTIs COVID Post- MTIs COVID Pre-COVID MTIs 100 86 59 34 22 Blue Bronze Silver Gold Diamond Lapses by status (relative to blue) -10% -8% -6% -4% -2% 0% 2% 4% 6% 8% H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 -- 50 of 74 -- 51 Vitality Health Vitality Life -- 51 of 74 -- 52 UK Composite Normalised operating profit Earned premiums New business Lives covered +14% +11% +19% +11% to £83.4m to £989.2m to £176m to 1.72m lives 2019 2020 2021 2022 2023 2019 2020 2021 2022 2023 GBP millions GBP millions 2019 2020 2021 2022 2023 2019 2020 2021 2022 2023 GBP millions Financial strength and brand Insurer Financial Strength Rating of 'A’ Fitch ratings UK financially self sufficient, no further funding needed from Discovery Source: H1 2023 Vitality Brand Survey, Immerse UK Highest-ever brand awareness since inception 56 55 57 59 56 57 55 59 60 61 61 60 59 61 14 19 25 29 30 37 50 50 51 53 57 55 54 58 2014 2023 Promoted brand awareness Competitor average vs Vitality -- 52 of 74 -- 53 2019 2020 2021 2022 2023 2019 2020 2021 2022 2023 VitalityHealth Normalised operating profit Earned premiums New business Lives covered -9% +11% +12% +13% to £59.9m to £623.6m to £96.3m to 959k lives GBP millions GBP millions GBP millions 2019 2020 2021 2022 2023 2019 2020 2021 2022 2023 -- 53 of 74 -- 54 A changing healthcare landscape Pressures in the NHS1 Increased demand for health insurance - 2,000,000 4,000,000 6,000,000 8,000,000 People on waiting list Within 18 weeks 18-52 weeks > 1 year NHS waiting lists at their highest levels since pre-20072 1 Institute for Government: The NHS productivity puzzle, 2 NHS Digital, 3 Nuffield Trust: Quality Watch, 4 LaingBuisson Health Cover Report (18 Edition), 5 Including authorisations from additional out-of-hospital cover 6,200 6,400 6,600 6,800 7,000 7,200 7,400 7,600 7,800 8,000 2017 2018 2019 2020 2021 2022* People covered by health insurance4 (000) *Estimate based on 2021 growth. Challenges in accessing care and treatment Cancer waiting time target only met once in 9 years3 0% 10% 20% 30% 40% Oct-09 Aug-10 Jun-11 Apr-12 Feb-13 Dec-13 Oct-14 Aug-15 Jun-16 Apr-17 Feb-18 Dec-18 Oct-19 Aug-20 Jun-21 Apr-22 Feb-23 Patients waiting over 2 months for first cancer treatment following referral Lack of capital investment The UK’s long-standing minimal capital spend on health care relative to other countries, where the maintenance backlog has increased to £10.75bn Bed occupancy Delayed discharges leave around 10% of the total number of beds – equivalent to 20 hospitals – occupied with patients who have no medical need to be there but, usually, remain there due to a lack of available care outside the hospital system Staff shortages The NHS is operating with more than 150,000 fewer full-time staff than it needs Experienced staff attrition The leaver rate is at a record high of 12.5% Increased utilisation post-COVID H2 2019 H2 2020 H2 2021 H2 2022 H2 2023 Authorisations per 1 000 lives 27% increase in authorisations5 Target = 15% -- 54 of 74 -- 55 Vitality is transforming the role of health insurance Moving from a supplementary product to holistic cover The first insurer to offer an end-to-end health insurance claims journey 56,000+ monthly visits to Care Hub 40% authorisations complete online 83% online mental health bookings 71% online physio bookings Prioritising prevention through the Vitality programme 0% 10% 20% 30% 40% 50% 60% Optical and dental module Talking therapies Phyiotherapy Virtual GP Expansive Primary Care and the first insurer to introduce Virtual GP 58% of claims are for Primary Care Proven track record of delivering superior patient outcomes -53% -61% -42% -9% Less frequent change of consultant (90 DAYS) Length of stay Readmission rates (28 DAYS) Total generated spend Non-Premier Premier Premier Consultants performance 2022 50% 60% 70% 80% 90% 100% Musculoskeletal Oncology Cardiac More activity No activity 1 . LaingBuisson Health Cover report 18 Edition. Based on insured premiums only (excluding Trust) * Estimated market growth based on LaingBuisson 2021 data Driving significant growth VitalityHealth is now the 3rd largest health insurer by earned premium1 VitalityHealth and Market growth (lives) 2017-2022 +14%* +60% 0% 10% 20% 30% 40% 50% 60% 70% PMI market VitalityHealth Vitality has grown at a 4x faster rate than the market In-hospital claims costs and physical activity -- 55 of 74 -- 56 2019 2020 2021 2022 2023 VitalityLife Normalised operating profit Earned premiums New business Lives covered +47% +10% +30% +9% to £48.5m to £365.6m to £80.3m to 765k lives GBP millions GBP millions GBP millions 2019 2020 2021 2022 2023 2019 2020 2021 2022 2023 2019 2020 2021 2022 2023 -- 56 of 74 -- 57 Outstanding new business growth supported by positive experience variances Outstanding growth in challenging market conditions Positive lapse experience amid cost-of-living crisis 100 91 73 72 71 2018/19 2019/20 202/21 2021/22 2022/23 Annualised lapse rate VitalityLife Market Share (IFA Channel) Market (excl. VL) 5% 32% VitalityLife Annual sales growth (all channels) GenRe, ProtectionPulse, June 2023 9% 10% 12% 13% 14% 14% 14% 15% Q3 2021 Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Market share -- 57 of 74 -- 58 Offsetting impacts from rise in interest rates VNB margin materially impacted by interest rates High inflation driving in-force premium increases -2% -1% 0% 1% 2% 3% 4% VNB margin before economic and expense impact Economic Unit expenses June 23 net VNB 1.8% IRR above RFR VNB margin (%) • Economic impact was the biggest driver for the reduction, both in terms of interest rate changes and inflationary affect on unit costs • However this was offset against higher premium indexation on the in-force book, contributing to profit growth -1.02% 3.00% 0% 5% 10% 15% 90 95 100 105 110 115 Effective RPI 2 +13.7% Effective premium increase In-force Indexed premium at July ’22 Indexation premium increases Total in-force index-linked premiums Indexation premium increases follow Retail Price Indexes (RPI) five months prior, capped at 10% 0.0% 0.5% 1.0% 1.5% 2.0% 2.5% 3.0% 3.5% 4.0% 4.5% 5.0% Jan 2016 Jan 2017 Jan 2018 Jan 2019 Jan 2020 Jan 2021 Jan 2022 Jan 2023 First hedge and swaption purchased Hedges moved onto PAC book Hedge strategy simplified UK 25-year SONIA rate Interest rates have increased Annual effective premium of Indexed plans relative to July ‘22 £18m positive operating profit impact -- 58 of 74 -- 59 USA -- 59 of 74 -- 60 Vitality Global Vitality Global Operating result FY19 FY20 FY21 FY22 FY23 Strong underlying growth, driven by deepened partner relationships, broadening the reach of Vitality assets and capabilities Vitality Network Vitality Health International +49% to $44m +74% to R777m Vitality Network Vitality Health International USA HEALTH -- 60 of 74 -- 61 Vitality Network FY19 FY20 FY21 FY22 FY23 Integrated API by insurance partners Revenue Insurance partners membership FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 Operating profit -1% to $1.4bn* +16% to R25.2bn +3% to $69.5m +20% to R1.2bn +8% to $23.1m +26% to R411m +23% to 3.7m -- 61 of 74 -- 62 Shared-Value insurance supporting positive outcomes for our partner in the 4th largest life insurance market globally Strong book growth driven by increasing distribution force High level of sustained engagement Positive actuarial dynamics driven by Shared Value model 64% 70% Engagement % of members earned a point Penetration Attachment rates $1.3bn Vitality ANP 1.5m Policies sold Relative hospitalisation rates Relative mortality rates Non-Vitality Vitality 18% lower Non-Vitality Vitality 43% lower Vitality ANP 2020 2021 2022 2023 2019 -- 62 of 74 -- 63 Shared-Value insurance supporting positive outcomes for our partner in the largest life insurance market globally Source: Distribution of Vitality PLUS and Vitality PLUS not elected within the ‘Super Preferred’; underwriting category for policies sold from 2017-2020. JH Vitality subset of members which had successive data, 2019 2016 2017 2018 2019 2020 2021 2022 Election rate Healthy Outcomes Annual Vitality Plus Sales Compared to the prior year, members reported the following on their Vitality Health Check: Improved Vitality PLUS election rates Launch of Vitality on all John Hancock products 36% Average annual growth rate 2016 2017 H1 H2 2019 2020 2021 2022 Launch of Vitality on all John Hancock products reported same or better BMI reported same or better cholesterol 54% reported same or better diastolic blood pressure 69% 82% 79% 66% reported same or better fasting glucose reported same or better systolic blood pressure Sales uplift 29 percentage point increase in Vitality plus election rates -- 63 of 74 -- 64 Key strategic focus areas Vitality Network Vitality Health International 1 Revenue growth through deepening of existing insurance partnerships and starting to participate in emerging profits 2 Targeted pursuit of new insurance partnerships, with a focus on expanding in the US 3 Unlock geared profits through operational efficiency and fixed investment largely based in South Africa USA HEALTH -- 64 of 74 -- 65 USA +137% to $22.6m +177% to R402m Year of launch or investment by VG 2020 2022 2009 2008 *section follows on slide HEALTH +64% to $55.5m VHI excluding PAHI FY19 FY20 FY21 FY22 FY23 VHI - Other VHI – PAHI Includes Amplify Health revenue from IP fees for health IP Including PAHI equity earnings VHI leverages the success of the mature PAHI to invest into high potential health markets Vitality Health International Revenue Operating result FY19 FY20 FY21 FY22 FY23 Driven largely by growth in PAHI -- 65 of 74 -- 66 VHI | Growth in high potential healthtech & insurance ventures USA HEALTH Health insurance HealthTech VUS continues to accelerate its development of the new personal pathways product with a robust pipeline of sales prospects and strong market interest for the health solution PAHI remains resilient and is supported by strong business fundamentals including a strong balance sheet with a comprehensive solvency ratio of 267% 28m lives and 45% growth in operating profit Digital health solutions have been established within Amplify Health, accelerated by the acquisition of AiDA Technologies. Substantial progress has been made in the design, specification and initial technology builds of 3 priority products While revenue has declined due to the conclusion of COVID government contracts recovery will be driven by new international contracts. One such opportunity is implementing a data science platform with AI-driven personalised health recommendations for Vitality UK -- 66 of 74 -- 67 Emerging markets of focus for Amplify Health Key Amplify Health markets (AIA Health TDA) Markets with AIA Vitality only Product footprint Committed: • Private Medical Insurance (PMI) product builder • Provider management consulting Committed: • Value, diagnostics, insights • Optical character recognition (OCR) • Fraud, Waste, & Abuse (FWA) + Pre-Auth Committed: • Health wallet • AI Claims • OCR Pipeline: • PMI product builder Committed: • Data diagnostics • OCR • FWA Pipeline: • Chronic Disease Management (CDM) Committed: • Value insights Committed: • Value, diagnostics, insights Pipeline: • FWA • OCR • Provider Management 5 major products Broad footprint Chronic disease management (CDM) Validates health risks and diagnosis, supports self-management, and incentivises behaviour modification Vitality Vitality identifies individuals’ health risks and motivates and incentivises them to modify relevant lifestyle behaviours to improve their overall health and wellbeing Provider management Analytic tools for provider performance profiles, alternative reimbursement models and network modeling Claims administration End-to-end solution that automates claims, improves cost control and enables better insights from claims data Fraud, waste, and abuse AI based outlier detection and flagging suspicious cases for assessors to review -- 67 of 74 -- 68 2019 2020 2021 2022 2023 PAHI licence Reinsurance to RMB1.3bn (RMB328m DSY’s share) 2019 2020 2021 2022 2023 2019 2020 2021 2022 2023 Investment income and gains Profit before investment income and gains 1 100% of PAHI Graphs and callouts on graphs are in Rands PAHI’s operating results pre-tax Discovery’s operating result after tax PAHI licence New business1Written premium1 +39% +76% -1% +11% to R3.4bn (R849m DSY’s share) to R596m to R8.7bn to R50.1bn +12% before investment income +22% PAHI licence written premium 2019 2020 2021 2022 2023 +31% +2% to RMB19.6bn +63% to RMB234m -9% to RMB3.4bn -- 68 of 74 -- 69 70% 78% 80% 83% 84% 2019 2020 2021 2022 2023 95% 100% 91% 92% 89% 2019 2020 2021 2022 2023 Assessments, reports, and actionable recommendations Effective incentivised wellness management programmes Products and services to support positive health outcomes Successful pivot to a health & wellness model Robust core capabilities positively impacting performance Superior profit margins Growth in net asset value Net asset value (RMBm)3 2022 profit margin2 1 Figures are for January to June for each financial year 2 Margins as reported by the different insurer’s in their Annual Financial Statements 3 100% of PAHI Persistency1 Combined ratio1 4.8% 1.2% 1.2% 1.8% 1.0% - 1 000 2 000 3 000 4 000 5 000 6 000 7 000 8 000 2020 2021 2022 2023 -- 69 of 74 -- 70 0 100 200 300 400 500 600 700 800 900 Jan Feb Mar Apr May Jun 2022 2023 2022 2023 Low economic growth, decrease in PAL agents, and COVID-19 impacted new business in last 2 years Initial new business slump recovered New products and growing channels PAHI licence business (RMBm) Number of existing PAL agents New products launched Growing alternative channels YTD cumulative new business change over FY 2023 (PAHI licence) Red door sales impacted by COVID-19 in 2023 Significant decrease in number of PAL agents Non-PAL new business (RMBm) 27% lower -9% -25% -20% -15% -10% -5% 0% Jul-2022 Aug-2022 Sep-2022 Oct-2022 Nov-2022 Dec-2022 Jan-2023 Feb-2023 Mar-2023 Apr-2023 May-2023 Jun-2023 0 100 200 300 400 500 600 700 800 900 2019 2020 2021 2022 2023 SuiShenYi channel impacted by legislative changes in 21/22 -- 70 of 74 -- 71 2022E 2025E 2030E Poor Aspirant Emerging MC Middle class Upper MC Affulent 1 BCG; 2 United Nations; 3 Economic Intelligence Unit August 2023, 4 2023 National Bureau of Statistics: “China Statistical Yearbook” CHI=Commercial Health Insurance, SHI = Social Health Insurance, OOP = Out of Pocket 5 National Healthcare Security administration; 6: National Development and Reform Commission, China Banking and Insurance Regulatory Commission; 7: China Banking and Insurance News Strong policy support Percentage older than 65 to double by 2050 Middle class & affluent to increase 80m by 2030 0 200 400 600 800 1 000 1 200 1 400 2022 2024 2026 2028 2030 2032 2034 2036 2038 2040 2042 2044 2046 2048 2050 <20 20-29 30-39 40-49 50-64 65 and above Population by age band2 (m) Population by income bracket1 (m) 473 554 Policy commitment to public provision of healthcare and Social Health Insurance funding National Healthcare Security Administration (NHSA) recently reinforced commitment to expanding the Social Health Insurance (SHI) provider network, enhancing and standardising service agreements, and improving reimbursement processes5 Policy commitment to private provision and private funding, to complement what is available in the public provider sector and SHI National Development and Reform Commission’s 14th Five-Year Plan for National Health emphasises promoting the supply of private health insurance. A joint announcement by 13 state departments contemplates Commercial Health Insurance (CHI) as a vital component of the healthcare system6 A progressive approach to ensuring that the public and private sectors work together, and do not bifurcate The National Financial Regulatory Administration and the NHSA are jointly working towards information-sharing between CHI and SHI information platforms. In June 2023, a draft information-sharing protocol was released to provincial Health Securities Administrations for review and comment7 442 477 504 538 571 603 2022 2023 E 202 4E 2025 E 2026 E 2027 E Healthcare expenditure (USD bn)3 SHI, CHI, and OOP4 68% 67% 66% 64% 29% 28% 27% 27% 3% 5% 7% 9% 2018 2021 2024E 2027E SHI OOP CHI Healthcare insurance increasingly important -- 71 of 74 -- 72 • Scaling the Bank to profit and positioning it as the face of the composite • Ensuring each business is market leader in terms of market share, margin, product and customer value • Scaling Ping An Health Insurance in a complex Chinese market • Monetising and scaling IP in Vitality Network with key partners • Globalising unique health assets • Growing VitaltyHealth on the back of a complex NHS environment • Using the Shared-Value Model to get superior ROC and growth in VitalityLife • Integration of Life and Health Perfect composite model, #1 in our chosen segments in every industry, and the Bank pivoting to growth as the composite-maker within SA A new generation life and health insurance composite, with integration at both a product and operational level and a seamless One Vitality client journey Leading wellness and healthcare platform that provides preeminent life and health insurers globally with our Vitality shared-value and health management capabilities to assist them in making their customers healthier, while ensuring their products are more competitive with better margins -- 72 of 74 -- 73 1 2 3 Growing quality earnings with a robust balance sheet A clear strategy per composite, intensifying focus on key initiatives and ceasing those with marginal benefits 4 +12% New business 64%Cash conversion +24%Operating profit 20% FLR 10.6% Investment in New excl discontinued UK Transitioning to IFRS 17 Evolving the Vitality Shared-Value Insurance Model -- 73 of 74 -- Discovery Group Copyright 2023 Discovery Limited is the licensed controlling company of the designated Discovery Insurance Group. Registration number: 1999/007789/06. Companies in the Group are licensed insurers and authorised financial services providers. 1 Discovery Place, Sandton, 2196 | www.discovery.co.za -- 74 of 74 --